Teladoc Health (NYSE:TDOC) Shares Climb 8.1% – Time to Buy?

Teladoc Health, Inc. (NYSE:TDOC) shot up 8.1% during mid-day trading on Tuesday. The company traded as high as $6.18 and last traded at $6.1950. 1,880,053 shares traded hands during mid-day trading, a decline of 63% from the average session volume of 5,040,161 shares. The stock had previously closed at $5.73.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on TDOC. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Teladoc Health in a report on Wednesday, August 19th. Citigroup dropped their price target on shares of Teladoc Health from $11.00 to $7.50 and set a “neutral” rating for the company in a research report on Monday, August 3rd. Bank of America boosted their price target on Teladoc Health from $9.00 to $10.50 and gave the company a “buy” rating in a research note on Tuesday, July 7th. Finally, Canaccord Genuity Group reduced their price target on Teladoc Health from $11.00 to $10.00 and set a “buy” rating on the stock in a research report on Thursday, July 30th. Five research analysts have rated the stock with a Buy rating, ten have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average price target of $7.54.

Teladoc Health Price Performance

The company’s 50-day moving average is $6.19 and its two-hundred day moving average is $6.89. The firm has a market cap of $1.13 billion, a P/E ratio of -6.31 and a beta of 2.14.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings data on Wednesday, July 29th. The health services provider reported ($0.21) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.25) by $0.04. Teladoc Health had a negative net margin of 7.13% and a negative return on equity of 12.15%. The firm had revenue of $606.93 million for the quarter, compared to the consensus estimate of $615.44 million. During the same period in the prior year, the company posted ($0.19) earnings per share. The business’s revenue for the quarter was down 4.0% on a year-over-year basis. Teladoc Health has set its Q3 2026 guidance at -0.300–0.200 EPS and its FY 2026 guidance at -1.000–0.750 EPS. On average, analysts expect that Teladoc Health, Inc. will post -0.92 EPS for the current fiscal year.

Insider Buying and Selling at Teladoc Health

In related news, CEO Charles III sold 17,805 shares of the firm’s stock in a transaction dated Friday, September 11th. The stock was sold at an average price of $6.10, for a total value of $108,610.50. Following the sale, the chief executive officer directly owned 465,535 shares of the company’s stock, valued at $2,839,763.50. This trade represents a 3.68% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Corporate insiders own 0.70% of the company’s stock.

Institutional Investors Weigh In On Teladoc Health

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Counterpoint Mutual Funds LLC lifted its stake in Teladoc Health by 1,017.4% in the 3rd quarter. Counterpoint Mutual Funds LLC now owns 1,650,165 shares of the health services provider’s stock valued at $9,571,000 after purchasing an additional 1,502,488 shares during the last quarter. Vontobel Holding Ltd. boosted its position in Teladoc Health by 98.4% in the third quarter. Vontobel Holding Ltd. now owns 93,210 shares of the health services provider’s stock valued at $541,000 after buying an additional 46,227 shares in the last quarter. ABS Direct Equity Fund LLC acquired a new stake in Teladoc Health in the second quarter valued at approximately $1,513,000. WINTON GROUP Ltd grew its stake in shares of Teladoc Health by 402.4% during the second quarter. WINTON GROUP Ltd now owns 227,100 shares of the health services provider’s stock worth $1,926,000 after buying an additional 181,900 shares during the last quarter. Finally, Nykredit A S bought a new position in shares of Teladoc Health in the 2nd quarter valued at $27,000. 76.82% of the stock is owned by institutional investors.

About Teladoc Health

Teladoc Health, Inc (NYSE: TDOC) provides virtual healthcare services and technology that connect patients with physicians, therapists and other healthcare professionals. Its platform supports general medical care, specialist consultations, mental health services, chronic condition management and related healthcare programs through digital and remote-care channels.

The company’s offerings include Teladoc’s telehealth services, BetterHelp’s online counseling and therapy platform, and chronic care solutions developed through Livongo, which Teladoc acquired in 2020.